Glutathione: A radical treatment for cystic fibrosis lung disease?

Chest

Volumn 127, Issue 1, 2005, Pages 12-14

  Day, Brian J ^a,b  

^a National Jewish Medical and Research Center ^*

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; PLACEBO; TRANSMEMBRANE CONDUCTANCE REGULATOR;

DOSE RESPONSE; DRUG TOLERABILITY; EDITORIAL; GLUTATHIONE METABOLISM; GRAM NEGATIVE INFECTION; HUMAN; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; LUNG FUNCTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; CHEMISTRY; CYSTIC FIBROSIS; INHALATIONAL DRUG ADMINISTRATION; NOTE; PHYSIOLOGY;

ADMINISTRATION, INHALATION; CYSTIC FIBROSIS; GLUTATHIONE; HUMANS;

EID: 13844306745     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.1.12     Document Type: Editorial

References (17)

1. Roum JH, Buhl R, McElvaney NG, et al. Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol 1993; 75:2419-2424
2. Brown RK, Wyatt H, Price JF, et al. Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. Eur Respir J 1996; 9:334-339
3. Linsdell P, Hanrahan JW. Glutathione permeability of CFTR. Am J Physiol 1998; 275:C323-C326
4. Gao L, Kim KJ, Yankaskas JR, et al. Abnormal glutathione transport in cystic fibrosis airway epithelia. Am J Physiol 1999; 277:L113-L118
5. Kogan I, Ramjeesingh M, Li C, et al. CFTR directly mediates nucleotide-regulated glutathione flux. EMBO J 2003; 22: 1981-1989
6. Velsor LW, van Heeckeren A, Day BJ. Antioxidant imbalance in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice. Am J Physiol Lung Cell Mol Physiol 2001; 281:L31-L38
7. Venglarik CJ, Giron-Calle J, Wigley AF, et al. Hypochlorous acid alters bronchial epithelial cell membrane properties and prevention by extracellular glutathione. J Appl Physiol 2003; 95:2444-2452
8. Cantin AM, North SL, Hubbard RC, et al. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 1987; 63:152-157
9. Pacht ER, Timerman AP, Lykens MG, et al. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 1991; 100:1397-1403
10. Cantin AM, Hubbard RC, Crystal RG. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1989; 139:370-372
11. Baz MA, Tapson VF, Roggli VL, et al. Glutathione depletion in epithelial lining fluid of lung allograft patients. Am J Respir Crit Care Med 1996; 153:742-746
12. Buhl R, Jaffe HA, Holroyd KJ, et al. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 1989; 2:1294-1298
13. Moss M, Guidot DM, Wong-Lambertina M, et al. The effects of chronic alcohol abuse on pulmonary glutathione homeostasis. Am J Respir Crit Care Med 2000; 161:414-419
14. Brown DM, Beswick PH, Bell KS, et al. Depletion of glutathione and ascorbate in lung lining fluid by respirable fibres. Ann Occup Hyg 2000; 44:101-108
15. Day BJ, van Heeckeren AM, Min E, et al. Role for cystic fibrosis transmembrane conductance regulator protein in a glutathione response to bronchopulmonary Pseudomonas infection. Infect Immun 2004; 72:2045-2051
16. Roum JH, Borok Z, McElvaney NG, et al. Glutathione aerosol suppresses lung epithelial surface inflammatory cell-derived oxidants in cystic fibrosis. J Appl Physiol 1999; 87:438-443
17. Griese M, Ramakers J, Krasselt A, et al. Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis. Am J Respir Crit Care Med 2004; 169:822-828